| 摘要: |
|
| 关键词: 程序性死亡蛋白1抑制剂 程序性死亡蛋白配体1抑制剂 替雷利珠单抗 重症多形红斑 中毒性表皮坏死松解症 |
| DOI：10.16781/j.CN31-2187/R.20220631 |
| 投稿时间：2022-07-28修订日期：2023-04-25 |
| 基金项目: |
|
| Toxic epidermal necrolysis caused by tislelizumab: a case report |
| DING Junli,XU Lezhen,ZHAO Jingyu,GAO Yangjie,GU Julin* |
(Department of Dermatology, The Third Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai 201805, China
*Corresponding author) |
| Abstract: |
|
| Key words: programmed death-1 inhibitor programmed death-ligand 1 inhibitor tislelizumab Stevens-Johnson syndrome toxic epidermal necrolysis |
